Examining How Heart Disease Risk Factors Affect Healthy Aging (The Chicago Healthy Aging Study [CHAS])
CHAS
Low CV Risk, Ages 25-44 & CV/Non-CV Outcomes, Ages 65+
2 other identifiers
observational
1,395
1 country
1
Brief Summary
Heart disease is the leading cause of death in the United States and is responsible for 30% of all deaths in the United States. This study will examine how risk factors for heart disease in young and middle aged people affect people's health as they grow older.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2007
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2007
CompletedFirst Submitted
Initial submission to the registry
February 27, 2008
CompletedFirst Posted
Study publicly available on registry
February 29, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedMay 3, 2023
May 1, 2023
2.8 years
February 27, 2008
May 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Subclinical atherosclerosis, CVD-related markers of inflammation, and levels of physical performance
Measured during participant's one (baseline) study visit
Eligibility Criteria
Original participants in the Chicago Heart Association (CHA) Detection in Industry study (1967 to 1973) who still reside in the Greater Chicagoland area.
You may qualify if:
- Participated in the CHA study
- Lives in the Greater Chicagoland area
You may not qualify if:
- Severely ill, disabled, or cognitively impaired
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Preventive Medicine Research Clinic
Chicago, Illinois, 60611, United States
Biospecimen
Whole blood, serum, white cells, and urine
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martha L. Daviglus, MD, PhD
Northwestern University Feinberg School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2008
First Posted
February 29, 2008
Study Start
November 1, 2007
Primary Completion
August 1, 2010
Study Completion
December 1, 2010
Last Updated
May 3, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share
No plan to share.